Business

Abbott Laboratories Pakistan : Transmission of Annual Report for the Year Ended 31 December 2024

Abbott Laboratories Pakistan : Transmission of Annual Report for the Year Ended 31 December

articleAbbott Laboratories Pakistan LimitedMarch 24, 20253/company/abbott-laboratories-pakistan-ltd/news/abbott-laboratories-pakistan-transmission-of-annual-report-for-the-year-ended-31-december-2024
Abbott Laboratories Pakistan : Transmission of Annual Report for the Year Ended 31 December 2024

About this update from Abbott Laboratories Pakistan Limited

[{"type":"text","content":"2024 ANNUAL REPORT\n Throughout our long history, our focus has never veered from improving the health of people who count on us. We have continuously reinvented Abbott to meet the needs of every age and stage of a person's life.\n We believe the best medical products are ones that help the most people. We're well-practiced in delivering through the complexity required to maximize access and affordability across our businesses in branded-generic pharmaceuticals, nutrition, diagnostics and medical devices.\n Through its presence in diversified business segments, Abbott has continued to deliver consistent growth and shareholder returns. We're strengthening the resilience of our company so that we can continue to shape the future of healthcare and help more people, in more places, lead fuller, healthier lives.\n Table of Contents\n 02 Vision and Mission\n 04 Our Core Values\n 06 History of Major Events\n 08 Geographical Presence\n 09 Ownership and Group Structure\n 10 Corporate Information\n 11 Organizational Chart\n 12 Established Pharmaceuticals\n 14 Nutrition\n 16 Diagnostics\n 18 Diabetes Care\n 20 Key Brands\n 24 Product Launches\n 26 Awards and Recognitions\n 28 Significant factors effecting the external environment and the organization's response\n 30 Objectives, Strategy and Resource\n Allocation Plans\n 32 Key resources and capabilities of the company which provides sustainable competitive advantage\n Our Vision\n 33 SWOT Analysis\n 34 Risks and Opportunities\n 36 Key Risks & Opportunities\n 38 Sustainability and Corporate Social Responsibility\n 44 CEO's Message\n 46 Directors' Profiles\n 48 Corporate Governance\n 53 Salient Features of Terms of Reference of Board Committees\n 54 Board Committees Attendance\n 55 Gender Pay Gap Statement\n 56 Stakeholders Relationship and Engagement\n 57 Future Outlook\n 58 Review Report by the Chairman\n 59 Review Report by the Chairman (Urdu)\n 60 Directors' Report\n 71 Directors' Report (Urdu)\n 72 2024 Financial Report\n To be the most admired healthcare company in Pakistan.\n Our Mission\n To deliver consistently superior products and services which contribute significantly to improve the quality of life of consumers.\n Our Core Values\n Our purpose as a business is clear: we help people live healthier, fuller lives through our life-changing products, solutions and technologies.\n F...

More updates from Abbott Laboratories Pakistan Limited